- Home
- Bvf Inc/il
Insider Trading History of Bvf Inc/il
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bvf Inc/il since 2005.
The trader's CIK number is 1056807.
At the time of the last reporting, Bvf Inc/il was the Other of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
Note that in the past
BVF INC/IL also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Curis Inc (CRIS) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | CRIS | 0 | $0 | 2,970,000 | $3,415,499 | 0 | $0 |
Yearly summary of insider trading at Nps Pharmaceuticals Inc (NPSP) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | NPSP | 413,500 | $1,559,202 | 474,800 | $4,107,217 | 0 | $0 |
Yearly summary of insider trading at Arqule Inc (ARQL) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | ARQL | 6,760,223 | $24,460,865 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ligand Pharmaceuticals Inc (LGND) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | LGND | 43,736 | $87,472 | 5,524,515 | $14,540,618 | 0 | $0 |
| 2008 | LGND | 3,763,327 | $6,651,253 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Repligen Corp (RGEN) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | RGEN | 0 | $0 | 451,800 | $2,492,112 | 0 | $0 |
Yearly summary of insider trading at Combinatorx, Inc (CRXX) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | CRXX | 0 | $0 | 3,177,899 | $2,542,319 | 0 | $0 |
| 2008 | CRXX | 5,900,972 | $3,653,447 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Adolor Corp (ADLR) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | ADLR | 1,835,019 | $5,263,705 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Avigen Inc \de (AVGN) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | AVGN | 0 | $0 | 472,826 | $709,239 | 0 | $0 |
| 2008 | AVGN | 970,800 | $713,193 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Capstone Therapeutics Corp. (CAPS) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | CAPS | 1,186,600 | $790,338 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pharmacopeia Drug Discovery Inc (PCOP) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | PCOP | 788,000 | $709,200 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Supergen Inc (SUPG) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | SUPG | 0 | $0 | 119,501 | $337,218 | 0 | $0 |
Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | NBIX | 0 | $0 | 905,100 | $2,471,154 | 0 | $0 |
| 2009 | NBIX | 134,100 | $409,687 | 0 | $0 | 0 | $0 |
| 2008 | NBIX | 2,212,247 | $9,349,801 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Amag Pharmaceuticals, Inc. (AVM) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | AVM | 0 | $0 | 289,970 | $4,516,480 | 0 | $0 |
| 2005 | AVM | 0 | $0 | 213,800 | $2,557,261 | 0 | $0 |
Yearly summary of insider trading at Sgx Pharmaceuticals, Inc. (SGXP) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | SGXP | 2,403,357 | $5,541,713 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neurobiological Technologies Inc /ca/ (NTII) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | NTII | 0 | $0 | 4,606,395 | $4,191,819 | 0 | $0 |
| 2007 | NTII | 47,000 | $114,069 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dynavax Technologies Corp (DVAX) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | DVAX | 0 | $0 | 3,853,806 | $8,411,665 | 0 | $0 |
Yearly summary of insider trading at Catalyst Biosciences, Inc. (TRGT) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | TRGT | 35,216 | $107,078 | 638,400 | $15,063,048 | 0 | $0 |
Yearly summary of insider trading at Facet Biotech Corp (FACT) by Bvf Inc/il
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | FACT | 467,549 | $7,324,400 | 0 | $0 | 0 | $0 |
Insider trading activities at 18 companies by Bvf Inc/il:
1. Curis Inc (CRIS)
2. Nps Pharmaceuticals Inc (NPSP)
3. Arqule Inc (ARQL)
4. Ligand Pharmaceuticals Inc (LGND)
5. Repligen Corp (RGEN)
6. Combinatorx, Inc (CRXX)
7. Adolor Corp (ADLR)
8. Avigen Inc \de (AVGN)
9. Capstone Therapeutics Corp. (CAPS)
10. Pharmacopeia Drug Discovery Inc (PCOP)
11. Supergen Inc (SUPG)
12. Neurocrine Biosciences Inc (NBIX)
13. Amag Pharmaceuticals, Inc. (AVM)
14. Sgx Pharmaceuticals, Inc. (SGXP)
15. Neurobiological Technologies Inc /ca/ (NTII)
16. Dynavax Technologies Corp (DVAX)
17. Catalyst Biosciences, Inc. (TRGT)
18. Facet Biotech Corp (FACT)
Table 1. Insider trading of Curis Inc (CRIS) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-04-27 | CRIS | Sale | 2,970,000 | 1.15 | 3,415,499 |
Table 2. Insider trading of Nps Pharmaceuticals Inc (NPSP) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-09-19 | NPSP | Sale | 191,600 | 8.55 | 1,638,563 |
| 2008-09-22 | NPSP | Sale | 283,200 | 8.72 | 2,468,654 |
| 2008-03-19 | NPSP | Buy | 3,400 | 3.90 | 13,260 |
| 2008-03-17 | NPSP | Buy | 45,500 | 3.80 | 172,900 |
| 2008-03-12 | NPSP | Buy | 38,600 | 3.82 | 147,452 |
| 2008-03-11 | NPSP | Buy | 53,900 | 3.71 | 200,184 |
| 2008-03-10 | NPSP | Buy | 126,000 | 3.73 | 469,350 |
| 2008-03-07 | NPSP | Buy | 146,100 | 3.81 | 556,056 |
Table 3. Insider trading of Arqule Inc (ARQL) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-11-21 | ARQL | Buy | 340,900 | 2.40 | 816,455 |
| 2008-11-19 | ARQL | Buy | 294,413 | 2.65 | 780,194 |
| 2008-11-10 | ARQL | Buy | 1,338,500 | 2.35 | 3,145,475 |
| 2008-11-12 | ARQL | Buy | 377,000 | 2.45 | 923,650 |
| 2008-11-11 | ARQL | Buy | 412,200 | 2.25 | 927,450 |
| 2008-03-10 | ARQL | Buy | 1,363,283 | 3.90 | 5,316,803 |
| 2008-02-22 | ARQL | Buy | 8,200 | 4.75 | 38,950 |
| 2008-02-21 | ARQL | Buy | 186,000 | 4.95 | 920,885 |
| 2008-02-20 | ARQL | Buy | 28,100 | 5.05 | 141,905 |
| 2008-02-15 | ARQL | Buy | 49,600 | 5.08 | 252,067 |
| 2008-02-19 | ARQL | Buy | 32,300 | 5.10 | 164,697 |
| 2008-02-11 | ARQL | Buy | 83,700 | 4.96 | 414,817 |
| 2008-02-08 | ARQL | Buy | 259,000 | 4.98 | 1,289,302 |
| 2008-02-07 | ARQL | Buy | 368,300 | 4.90 | 1,803,933 |
| 2008-02-01 | ARQL | Buy | 165,000 | 5.00 | 825,495 |
| 2008-02-04 | ARQL | Buy | 210,100 | 5.08 | 1,067,938 |
| 2008-01-31 | ARQL | Buy | 510,000 | 4.71 | 2,404,140 |
| 2008-01-23 | ARQL | Buy | 154,600 | 4.47 | 690,907 |
| 2008-01-15 | ARQL | Buy | 107,300 | 4.65 | 498,623 |
| 2008-01-14 | ARQL | Buy | 24,800 | 4.50 | 111,600 |
| 2008-01-10 | ARQL | Buy | 324,227 | 4.32 | 1,399,687 |
| 2008-01-09 | ARQL | Buy | 122,700 | 4.29 | 525,892 |
Table 4. Insider trading of Ligand Pharmaceuticals Inc (LGND) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-08-24 | LGND | Sale | 4,552,550 | 2.57 | 11,700,053 |
| 2009-07-01 | LGND | Sale | 142,700 | 2.97 | 423,676 |
| 2009-06-26 | LGND | Sale | 479,256 | 2.93 | 1,402,782 |
| 2009-06-29 | LGND | Sale | 58,616 | 2.94 | 172,565 |
| 2009-06-25 | LGND | Sale | 291,393 | 2.89 | 841,542 |
| 2009-01-23 | LGND | Buy | 39,728 | 2.00 | 79,456 |
| 2009-01-26 | LGND | Buy | 4,008 | 2.00 | 8,016 |
| 2008-12-05 | LGND | Buy | 28,283 | 1.98 | 56,056 |
| 2008-12-04 | LGND | Buy | 96,300 | 2.04 | 195,970 |
| 2008-12-03 | LGND | Buy | 27,739 | 1.95 | 54,063 |
| 2008-12-01 | LGND | Buy | 131,700 | 1.86 | 245,357 |
| 2008-12-02 | LGND | Buy | 193,000 | 1.90 | 365,928 |
| 2008-11-28 | LGND | Buy | 240,600 | 1.99 | 479,515 |
| 2008-11-26 | LGND | Buy | 1,350,000 | 1.95 | 2,633,850 |
| 2008-11-24 | LGND | Buy | 143,000 | 2.01 | 287,573 |
| 2008-11-25 | LGND | Buy | 353,000 | 1.77 | 625,163 |
| 2008-11-21 | LGND | Buy | 186,744 | 1.78 | 331,657 |
| 2008-11-20 | LGND | Buy | 9,200 | 1.26 | 11,628 |
| 2008-11-18 | LGND | Buy | 81,400 | 1.38 | 112,494 |
| 2008-11-19 | LGND | Buy | 33,000 | 1.39 | 45,903 |
| 2008-11-17 | LGND | Buy | 92,000 | 1.33 | 122,268 |
| 2008-11-14 | LGND | Buy | 210,000 | 1.31 | 275,520 |
| 2008-11-12 | LGND | Buy | 14,511 | 1.35 | 19,560 |
| 2008-11-13 | LGND | Buy | 94,000 | 1.34 | 126,148 |
| 2008-11-11 | LGND | Buy | 167,850 | 1.39 | 233,311 |
| 2008-11-07 | LGND | Buy | 113,000 | 1.41 | 159,217 |
| 2008-11-10 | LGND | Buy | 198,000 | 1.36 | 270,072 |
Table 5. Insider trading of Repligen Corp (RGEN) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-07-06 | RGEN | Sale | 450,800 | 5.52 | 2,486,612 |
| 2009-07-07 | RGEN | Sale | 1,000 | 5.50 | 5,500 |
Table 6. Insider trading of Combinatorx, Inc (CRXX) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-12-22 | CRXX | Sale | 3,177,899 | .80 | 2,542,319 |
| 2008-12-05 | CRXX | Buy | 1,530,572 | .57 | 870,895 |
| 2008-12-04 | CRXX | Buy | 10,300 | .55 | 5,665 |
| 2008-12-03 | CRXX | Buy | 13,400 | .54 | 7,209 |
| 2008-12-01 | CRXX | Buy | 26,800 | .55 | 14,740 |
| 2008-12-02 | CRXX | Buy | 9,800 | .55 | 5,350 |
| 2008-11-26 | CRXX | Buy | 6,600 | .49 | 3,260 |
| 2008-11-25 | CRXX | Buy | 12,300 | .47 | 5,744 |
| 2008-11-24 | CRXX | Buy | 83,100 | .45 | 37,395 |
| 2008-11-21 | CRXX | Buy | 12,000 | .45 | 5,400 |
| 2008-11-14 | CRXX | Buy | 9,200 | .60 | 5,483 |
| 2008-11-12 | CRXX | Buy | 3,600 | .60 | 2,156 |
| 2008-11-13 | CRXX | Buy | 9,000 | .60 | 5,400 |
| 2008-11-11 | CRXX | Buy | 139,100 | .60 | 83,181 |
| 2008-11-07 | CRXX | Buy | 109,700 | .58 | 63,187 |
| 2008-11-10 | CRXX | Buy | 14,000 | .58 | 8,119 |
| 2008-11-05 | CRXX | Buy | 180,400 | .60 | 108,059 |
| 2008-11-06 | CRXX | Buy | 11,200 | .59 | 6,574 |
| 2008-10-16 | CRXX | Buy | 2,031,000 | .65 | 1,320,150 |
| 2008-10-15 | CRXX | Buy | 712,000 | .65 | 462,800 |
| 2008-10-13 | CRXX | Buy | 25,500 | .65 | 16,549 |
| 2008-10-10 | CRXX | Buy | 58,300 | .60 | 34,863 |
| 2008-10-08 | CRXX | Buy | 103,100 | .62 | 63,818 |
| 2008-10-07 | CRXX | Buy | 790,000 | .66 | 517,450 |
Table 7. Insider trading of Adolor Corp (ADLR) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-10-31 | ADLR | Buy | 1,000 | 2.95 | 2,950 |
| 2008-10-30 | ADLR | Buy | 31,500 | 2.94 | 92,641 |
| 2008-10-29 | ADLR | Buy | 56,400 | 2.79 | 157,581 |
| 2008-10-27 | ADLR | Buy | 64,400 | 3.12 | 201,185 |
| 2008-10-28 | ADLR | Buy | 1,351,119 | 2.78 | 3,752,057 |
| 2008-10-22 | ADLR | Buy | 71,400 | 3.24 | 231,336 |
| 2008-10-23 | ADLR | Buy | 132,300 | 3.22 | 426,006 |
| 2008-10-16 | ADLR | Buy | 18,900 | 3.12 | 58,911 |
| 2008-10-15 | ADLR | Buy | 51,000 | 3.08 | 156,978 |
| 2008-10-13 | ADLR | Buy | 48,500 | 3.24 | 157,285 |
| 2008-10-14 | ADLR | Buy | 8,500 | 3.15 | 26,775 |
Table 8. Insider trading of Avigen Inc \de (AVGN) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-11-18 | AVGN | Sale | 626 | 1.50 | 939 |
| 2009-10-21 | AVGN | Sale | 472,200 | 1.50 | 708,300 |
| 2008-11-18 | AVGN | Buy | 128,000 | .73 | 94,080 |
| 2008-11-19 | AVGN | Buy | 30,300 | .75 | 22,694 |
| 2008-11-13 | AVGN | Buy | 26,500 | .75 | 19,795 |
| 2008-11-10 | AVGN | Buy | 145,400 | .73 | 106,432 |
| 2008-11-12 | AVGN | Buy | 82,000 | .75 | 61,418 |
| 2008-11-11 | AVGN | Buy | 75,200 | .74 | 55,347 |
| 2008-11-11 | AVGN | Buy | 75,200 | .74 | 55,347 |
| 2008-11-12 | AVGN | Buy | 82,000 | .75 | 61,418 |
| 2008-11-10 | AVGN | Buy | 145,400 | .73 | 106,432 |
| 2008-11-07 | AVGN | Buy | 40,400 | .72 | 29,249 |
| 2008-11-06 | AVGN | Buy | 87,100 | .71 | 61,753 |
| 2008-11-04 | AVGN | Buy | 53,300 | .74 | 39,228 |
Table 9. Insider trading of Capstone Therapeutics Corp. (CAPS) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-10-13 | CAPS | Buy | 2,600 | .63 | 1,638 |
| 2008-10-10 | CAPS | Buy | 237,500 | .57 | 136,562 |
| 2008-10-14 | CAPS | Buy | 946,500 | .69 | 652,138 |
Table 10. Insider trading of Pharmacopeia Drug Discovery Inc (PCOP) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-11-05 | PCOP | Buy | 788,000 | .90 | 709,200 |
Table 11. Insider trading of Supergen Inc (SUPG) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-05-09 | SUPG | Sale | 4,300 | 2.69 | 11,571 |
| 2008-05-06 | SUPG | Sale | 1,500 | 2.75 | 4,125 |
| 2008-05-07 | SUPG | Sale | 6,494 | 2.71 | 17,605 |
| 2008-05-02 | SUPG | Sale | 14,207 | 2.83 | 40,262 |
| 2008-05-01 | SUPG | Sale | 93,000 | 2.83 | 263,655 |
Table 12. Insider trading of Neurocrine Biosciences Inc (NBIX) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-04-09 | NBIX | Sale | 94,000 | 2.76 | 259,252 |
| 2010-04-12 | NBIX | Sale | 104,000 | 2.80 | 291,408 |
| 2010-03-30 | NBIX | Sale | 104,000 | 2.70 | 280,800 |
| 2010-03-31 | NBIX | Sale | 1,000 | 2.70 | 2,700 |
| 2010-03-29 | NBIX | Sale | 77,100 | 2.70 | 208,324 |
| 2010-03-26 | NBIX | Sale | 31,200 | 2.70 | 84,240 |
| 2010-03-25 | NBIX | Sale | 304,800 | 2.70 | 822,960 |
| 2010-03-22 | NBIX | Sale | 72,000 | 2.77 | 199,368 |
| 2010-03-23 | NBIX | Sale | 29,000 | 2.75 | 79,750 |
| 2010-03-24 | NBIX | Sale | 88,000 | 2.75 | 242,352 |
| 2009-01-22 | NBIX | Buy | 6,900 | 3.10 | 21,390 |
| 2009-01-23 | NBIX | Buy | 9,000 | 3.10 | 27,873 |
| 2009-01-21 | NBIX | Buy | 25,200 | 3.06 | 77,086 |
| 2009-01-20 | NBIX | Buy | 75,000 | 3.08 | 231,075 |
| 2009-01-15 | NBIX | Buy | 7,400 | 3.05 | 22,584 |
| 2008-12-30 | NBIX | Buy | 10,600 | 2.80 | 29,679 |
| 2008-12-01 | NBIX | Buy | 99,400 | 2.35 | 233,093 |
| 2008-11-24 | NBIX | Buy | 54,400 | 2.45 | 133,225 |
| 2008-10-10 | NBIX | Buy | 447,047 | 2.72 | 1,215,967 |
| 2008-07-08 | NBIX | Buy | 3,400 | 4.25 | 14,450 |
| 2008-07-07 | NBIX | Buy | 115,700 | 4.24 | 490,683 |
| 2008-07-02 | NBIX | Buy | 26,600 | 4.18 | 111,081 |
| 2008-07-03 | NBIX | Buy | 11,100 | 4.15 | 46,031 |
| 2008-05-27 | NBIX | Buy | 5,000 | 4.71 | 23,555 |
| 2008-05-28 | NBIX | Buy | 22,100 | 4.72 | 104,312 |
| 2008-05-15 | NBIX | Buy | 126,300 | 4.63 | 584,390 |
| 2008-05-16 | NBIX | Buy | 26,300 | 4.65 | 122,347 |
| 2008-03-20 | NBIX | Buy | 43,600 | 5.00 | 218,000 |
| 2008-03-18 | NBIX | Buy | 153,000 | 4.96 | 759,033 |
| 2008-03-12 | NBIX | Buy | 14,800 | 5.00 | 74,000 |
| 2008-03-11 | NBIX | Buy | 141,800 | 4.90 | 694,252 |
| 2008-03-10 | NBIX | Buy | 225,000 | 4.89 | 1,100,475 |
| 2008-03-07 | NBIX | Buy | 104,600 | 4.99 | 521,849 |
| 2008-03-06 | NBIX | Buy | 86,700 | 5.00 | 433,153 |
| 2008-03-04 | NBIX | Buy | 23,200 | 4.97 | 115,396 |
| 2008-03-03 | NBIX | Buy | 98,000 | 4.93 | 482,944 |
| 2008-02-28 | NBIX | Buy | 23,000 | 5.00 | 115,000 |
| 2008-02-29 | NBIX | Buy | 47,400 | 4.99 | 236,668 |
| 2008-02-26 | NBIX | Buy | 20,800 | 5.00 | 103,958 |
| 2008-02-25 | NBIX | Buy | 108,000 | 4.96 | 535,140 |
| 2008-02-22 | NBIX | Buy | 79,000 | 4.84 | 382,281 |
| 2008-02-21 | NBIX | Buy | 106,000 | 4.70 | 498,518 |
Table 13. Insider trading of Amag Pharmaceuticals, Inc. (AVM) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-01-12 | AVM | Sale | 158,700 | 15.72 | 2,494,922 |
| 2006-01-13 | AVM | Sale | 87,700 | 15.40 | 1,350,580 |
| 2005-01-13 | AVM | Sale | 43,570 | 15.40 | 670,978 |
| 2005-08-11 | AVM | Sale | 213,800 | 11.96 | 2,557,261 |
Table 14. Insider trading of Sgx Pharmaceuticals, Inc. (SGXP) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-07-11 | SGXP | Buy | 12,500 | 3.07 | 38,362 |
| 2008-07-10 | SGXP | Buy | 403,200 | 3.03 | 1,221,292 |
| 2008-07-09 | SGXP | Buy | 800,300 | 3.04 | 2,433,712 |
| 2008-07-08 | SGXP | Buy | 82,100 | 2.99 | 245,725 |
| 2008-06-18 | SGXP | Buy | 1,105,257 | 1.45 | 1,602,622 |
Table 15. Insider trading of Neurobiological Technologies Inc /ca/ (NTII) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-10-21 | NTII | Sale | 4,606,395 | .91 | 4,191,819 |
| 2007-11-06 | NTII | Buy | 47,000 | 2.43 | 114,069 |
Table 16. Insider trading of Dynavax Technologies Corp (DVAX) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-09-10 | DVAX | Sale | 1,212,106 | 2.77 | 3,351,473 |
| 2009-08-05 | DVAX | Sale | 396,000 | 2.00 | 793,584 |
| 2009-08-06 | DVAX | Sale | 3,500 | 2.03 | 7,101 |
| 2009-07-30 | DVAX | Sale | 15,600 | 1.85 | 28,906 |
| 2009-07-29 | DVAX | Sale | 113,500 | 1.85 | 210,315 |
| 2009-07-28 | DVAX | Sale | 49,000 | 1.85 | 90,650 |
| 2009-07-27 | DVAX | Sale | 245,100 | 1.99 | 488,239 |
| 2009-06-03 | DVAX | Sale | 1,292,000 | 1.99 | 2,565,912 |
| 2009-06-04 | DVAX | Sale | 505,000 | 1.68 | 846,885 |
| 2009-04-27 | DVAX | Sale | 22,000 | 1.30 | 28,600 |
Table 17. Insider trading of Catalyst Biosciences, Inc. (TRGT) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-10-16 | TRGT | Sale | 638,400 | 23.59 | 15,063,048 |
| 2009-07-14 | TRGT | Buy | 9,516 | 2.99 | 28,490 |
| 2009-07-13 | TRGT | Buy | 2,200 | 2.89 | 6,360 |
| 2009-07-09 | TRGT | Buy | 21,500 | 3.10 | 66,650 |
| 2009-07-10 | TRGT | Buy | 2,000 | 2.79 | 5,578 |
Table 18. Insider trading of Facet Biotech Corp (FACT) by Bvf Inc/il
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-02-09 | FACT | Buy | 19,000 | 15.69 | 298,072 |
| 2010-02-08 | FACT | Buy | 15,200 | 15.37 | 233,563 |
| 2010-02-05 | FACT | Buy | 5,000 | 15.00 | 75,000 |
| 2010-02-02 | FACT | Buy | 21,000 | 15.80 | 331,800 |
| 2010-02-03 | FACT | Buy | 12,138 | 15.80 | 191,780 |
| 2010-02-04 | FACT | Buy | 123,611 | 15.63 | 1,932,287 |
| 2010-01-27 | FACT | Buy | 118,000 | 15.66 | 1,848,234 |
| 2010-01-29 | FACT | Buy | 102,000 | 15.72 | 1,603,338 |
| 2010-01-28 | FACT | Buy | 51,600 | 15.70 | 810,326 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bvf Inc/il
(Other of Neurocrine Biosciences Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.